Literature DB >> 10403909

Reduced IL-4 and interferon-gamma (IFN-gamma) expression by CD4 T cells in patients with chronic lymphocytic leukaemia.

S J Hill1, S H Peters, M J Ayliffe, J Merceica, A S Bansal.   

Abstract

CD7 co-expression by CD4 T cells has been reported to be higher in the Th1 compared with the Th2 functional subset. Clinical immunodeficiency and immune dysregulation are more prevalent in the advanced stages of B cell chronic lymphocytic leukaemia (B-CLL). To analyse this further 25 patients with B-CLL and 11 healthy subjects were examined for cell surface CD7 and intracellular IFN-gamma and IL-4 expression in the peripheral blood CD4+ T helper cell population. Significantly decreased CD7, IFN-gamma and IL-4 expression was observed in the patients with B-CLL (P < 0.001). While CD7 negativity and IL-4 expression were more frequent in the later stages of the disease, this did not attain statistical significance. These results suggest a possible explanation for the reduced cellular and humoral immunity in B-CLL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403909      PMCID: PMC1905483          DOI: 10.1046/j.1365-2249.1999.00944.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Comparative analysis of whole blood lysis methods for flow cytometry.

Authors:  X Bossuyt; G E Marti; T A Fleisher
Journal:  Cytometry       Date:  1997-06-15

2.  Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance.

Authors:  C Rozman; E Montserrat; N Viñolas
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

3.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

4.  Autoimmunity in chronic lymphocytic leukaemia.

Authors:  T J Hamblin; D G Oscier; B J Young
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

5.  Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation.

Authors:  N E Kay
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

6.  Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. The French Cooperative Group on Chronic Lymphocytic Leukemia.

Authors: 
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

Review 7.  Immunobiology of chronic lymphocytic leukemia.

Authors:  A S Freedman
Journal:  Hematol Oncol Clin North Am       Date:  1990-04       Impact factor: 3.722

8.  T cell helper defect in patients with chronic lymphocytic leukemia.

Authors:  N Chiorazzi; S M Fu; G Montazeri; H G Kunkel; K Rai; T Gee
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

9.  Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety.

Authors:  O Ayanlar-Batuman; E Ebert; S P Hauptman
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

10.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.

Authors:  J L Binet; A Auquier; G Dighiero; C Chastang; H Piguet; J Goasguen; G Vaugier; G Potron; P Colona; F Oberling; M Thomas; G Tchernia; C Jacquillat; P Boivin; C Lesty; M T Duault; M Monconduit; S Belabbes; F Gremy
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

View more
  4 in total

1.  Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease.

Authors:  Shahryar Kiaii; Aniruddha Choudhury; Fariba Mozaffari; Eva Kimby; Anders Osterborg; Håkan Mellstedt
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

2.  Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.

Authors:  Farhad Jadidi-Niaragh; Ghasem Ghalamfarsa; Ali Memarian; Hossein Asgarian-Omran; Seyed Mohsen Razavi; Abdolfattah Sarrafnejad; Fazel Shokri
Journal:  Tumour Biol       Date:  2012-12-27

3.  Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia.

Authors:  Agnieszka Bojarska-Junak; Małgorzata Waldowska; Justyna Woś; Sylwia Chocholska; Iwona Hus; Waldemar Tomczak; Michał Dzik; Marek Hus; Jacek Roliński
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

4.  Recurrent Malignant Melanoma Presenting as Isolated Pleural Metastases in a Patient with Chronic Lymphocytic Leukemia.

Authors:  Kartik Anand; Shashank Cingam; Prakash Peddi
Journal:  Case Rep Oncol       Date:  2017-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.